Nov. 14 at 6:05 PM
$CPIX Co-Pilot is predicting a 30% move on the p3 announcement minimum. This could be next week or after thanksgiving. Usually, the MMers take it down 7 to 14 trading days before the news to accumulate and that is exactly what we saw here.
Co-Pilots Answer
If CPIX announces a Phase 3 trial for ifetroban, expect a double-digit percentage move upward (10–30%), with the potential for outsized gains due to its micro-cap status and the high-value orphan indication. However, volatility and financing risks could temper or reverse the rally quickly.
